Based in Israel, IMEL Biotherapeutics is a startup.
IMEL Biotherapeutics is developing a cell-based therapy using proprietary Mitochondrial Replaced Cells technology to treat patients with mitochondrial genetic or age-related disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.